Evidence map›Paper›PMID 41004538›Full record

ArticlePLoS pathogens2025

Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets.

Nina Derby, Brooke I Johnson, Sreya Biswas, Miranda Fischer, Katherine A Fancher, Cristina Luevano-Santos, Sofiya Yusova, Kimberly A Meyer, Yohannes M Abraham, Savannah S Lutz and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nina DerbySeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.ORCID 0000-0002-3281-4880
Brooke I JohnsonSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Sreya BiswasOregon Health and Science University, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Miranda FischerOregon Health and Science University, Vaccine and Gene Therapy Institute, Beaverton, Oregon, United States of America.
Katherine A FancherSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Cristina Luevano-SantosSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Sofiya YusovaOregon Health and Science University, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Kimberly A MeyerSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Yohannes M AbrahamSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Savannah S LutzOregon Health and Science University, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Cole FisherSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.
Maria Cristina PachecoDepartment of Pathology, Seattle Children's Hospital, Seattle, Washington, United States of America.
Jeremy V SmedleyUniversity of Louisiana at Lafayette, New Iberia Research Center, New Iberia, Louisiana, USA.
Benjamin J BurwitzOregon Health and Science University, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Donald L SodoraSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, Washington, United States of America.

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Mediators of fatty liver disease during HIV/SIV and cART treatmentR01AI134630 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI SODORA, DONALD L · 2018 to 2022
$4.5M
NIAID NIH HHS R01 AI134630NIH HHS P51 OD011092
6 · The paper itself

Abstract

Liver dysfunction is more common and more severe among people with HIV than in the general population. Our previous transcriptomic analysis identified an increased hepatic type-1 interferon (IFN-1) response in simian immunodeficiency virus (SIV) infected rhesus macaques, including pronounced upregulation of the IFN-1 stimulated gene product MX1. Here, we interrogated the role of different cell types in the IFN-1 response, focusing on macrophage subsets. During the acute phase of SIV infection, the expression of MX1 in liver biopsies was elevated in the resident macrophage Kupffer cells (KCs, CD163 + CD206+) as well as liver sinusoidal endothelial cells (LSECs, CD163- CD206+). Chronic infection was associated with increased MX1 expression both within KCs and the recruited monocyte-derived macrophages (MdMs, CD163 + CD206-) although the KCs were associated with the highest MX1 expression levels. We explored factors in the liver potentially associated with the macrophage IFN-1 response: 1) SIV DNA load, 2) bacterial DNA load (assessed via SIV DNA and 16S bacterial DNA qPCR, respectively), and 3) acute-phase hepatocyte lipid accumulation (steatosis). Both SIV and bacteria were elevated during chronic infection and directly correlated with MdM frequency. KC frequency did not correlate with SIV load but inversely correlated with bacterial load and also correlated directly with hepatocyte microvesicular steatosis in acute infection. Hepatocytes expressed variable levels of MX1 during acute and chronic infection. Overall, our data identify MdMs, LSECs and KCs as contributors to the heightened expression of MX1 in the liver during SIV infection. KCs express the highest levels of MX1 and therefore represent a potential target to reduce liver inflammation in people with HIV.

Indexed as

Interferon Type ILiverMacrophagesMonocytesMyxovirus Resistance ProteinsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsBiopsyKupffer CellsMacaca mulattaMaleInterferon Type IMyxovirus Resistance Proteins

Identifiers

PMID41004538
PMCPMC12543282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.